How Much Does
Ibogaine Treatment Cost?

Why Ibogaine Treatment Is an Investment, Not an Expense

The lifetime economic cost of untreated addiction is staggering. Researchers estimate that a single individual with a moderate-to-severe substance use disorder accumulates more than $250,000 in direct and indirect costs over their lifetime, including lost income, healthcare expenses, legal fees, and the financial toll on families. When viewed against that benchmark, ibogaine treatment at $7,500 to $14,500 is not an expense. it is one of the highest-return investments a person can make in their own life.

Conventional addiction treatment follows a cycle that most patients know intimately: a 30-day residential rehab stay costing $20,000 to $80,000, followed by a period of sobriety, then relapse, then another round of treatment. Studies consistently show that 40 to 60 percent of patients relapse within the first year of completing standard rehab. Many cycle through four, five, or six residential programs before achieving lasting recovery, accumulating treatment costs that dwarf the price of a single ibogaine treatment.

Long-term medication management for opioid use disorder, depression, or anxiety adds another layer of ongoing expense. Medication-assisted treatment regimens often run $3,000 to $12,000 annually, for years or decades. These costs compound while the underlying neurological drivers of addiction and mental health challenges remain unaddressed.

Ibogaine works differently. Rather than managing symptoms or substituting one dependency for another, ibogaine addresses the neurological root causes of addiction and trauma in a single intensive treatment cycle. Our programs at MindScape Retreat are designed to give you the deepest possible intervention, followed by 90 days of structured integration support, to make that one treatment cycle count.

Complete Pricing Breakdown

Everything Covered in Your All-Inclusive Program

Making Treatment Accessible

MindScape Retreat offers structured payment arrangements for patients who need flexibility. We recognize that the upfront cost of ibogaine treatment, even at its most accessible price point, can feel like a significant barrier. Our care coordinators work directly with patients to design a payment schedule that fits their situation. Please raise this during your initial consultation and we will find a path forward together.

Veterans and active-duty military personnel may have access to funding through veteran advocacy organizations that specifically support psychedelic-assisted treatment. Organizations such as MAPS, Heroic Hearts Project, and Veteran Mental Health Leadership Coalition have programs or referral networks that can help offset costs. Our team is familiar with these resources and can guide you through the application process.

Ibogaine treatment is not currently covered by most private health insurance plans in the United States, as ibogaine remains a Schedule I controlled substance domestically. This landscape is shifting as clinical evidence accumulates and legislative frameworks evolve. Some patients have utilized health sharing ministries, flexible spending accounts, or health savings accounts to cover a portion of costs. We recommend consulting your benefits coordinator about available options.

The tax deductibility of ibogaine treatment as a medical expense depends on your jurisdiction and individual circumstances. In the United States, unreimbursed medical expenses exceeding a threshold of your adjusted gross income may be deductible. We recommend consulting a tax professional who can evaluate your specific situation and provide guidance on documentation.

Ibogaine vs Traditional Addiction Treatment Costs

A single 30-day residential rehabilitation stay in the United States carries an average cost of $20,000 to $80,000 depending on the facility, with luxury programs reaching $100,000 or more per month. Despite this investment, conventional rehab carries a 40 to 60 percent relapse rate within the first year. Many patients complete multiple residential programs over years, with cumulative treatment costs that far exceed the price of ibogaine.

Outpatient addiction treatment programs average $5,000 to $10,000 per year for ongoing participation, not including medication costs. Medication-assisted treatment for opioid use disorder, including buprenorphine or methadone regimens, typically runs $3,000 to $12,000 annually and may continue indefinitely. These costs compound over years while patients remain tethered to a maintenance protocol rather than achieving full neurological freedom.

Ibogaine treatment at MindScape Retreat is a one-time investment of $7,500 to $14,500, all-inclusive. That single treatment cycle includes 90 days of structured integration support and is designed to address the neurological drivers of addiction rather than manage its symptoms. For patients who have cycled through conventional treatment without lasting results, ibogaine represents a fundamentally different cost-to-outcome proposition.

Pricing Questions